| Authors: |
McElvaney OJ; Department of Medicine, University of Washington, Seattle WA, USA; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, USA., Heltshe SL; Department of Medicine, University of Washington, Seattle WA, USA; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, USA; Department of Pediatrics, University of Washington, Seattle WA, USA., Sanders DB; Department of Pediatrics, Indiana University, Indianapolis IN, USA., West NE; Department of Medicine, Johns Hopkins University, Baltimore MD, USA., Fogarty B; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, USA., VanDevanter DR; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland OH, USA., Flume PA; Department of Pediatrics, Medical University of South Carolina, Charleston SC, USA; Department of Medicine, Medical University of South Carolina, Charleston SC, USA., Goss CH; Department of Medicine, University of Washington, Seattle WA, USA; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, USA; Department of Pediatrics, University of Washington, Seattle WA, USA. Electronic address: cgoss@medicine.washington.edu. |
